Beyond Air

Company Overview

Snapshot

Founded in May 2011, Beyond Air operates with 51–200 employees. The company has raised $69.54 million across 7 funding rounds from 2 investors. In September 2024, Beyond Air announced a $20.6 million private placement offering.

Business overview

Beyond Air is a Health Tech & Life Sciences company focused on developing treatment solutions for respiratory diseases. The company harnesses nitric oxide's pulmonary, antimicrobial, anti-inflammatory, and immunomodulatory mechanisms of action to provide treatment options. Its core technology, the LungFit platform, generates nitric oxide on-demand from ambient air for safe delivery to patients with various lung conditions. The LungFit PH system, specifically, is FDA-approved and utilizes patented Ionizer technology to generate unlimited, on-demand nitric oxide, serving markets in the United States and Canada.

Strategic signal

In September 2024, Beyond Air announced a $20.6 million private placement offering, signaling continued investor confidence and providing capital to advance its nitric oxide-based therapies. This financial move indicates the company's strategic efforts to secure resources for ongoing development and commercialization initiatives, particularly for its LungFit platform in the respiratory and critical care markets.

Company Intelligence Q&A

What is Beyond Air's primary focus?

Beyond Air is dedicated to developing treatment solutions for respiratory diseases, leveraging the therapeutic properties of nitric oxide for pulmonary, antimicrobial, anti-inflammatory, and immunomodulatory applications.

When did Beyond Air go public?

Beyond Air became public on NASDAQ in August 2015 with an Initial Public Offering.

What is the LungFit PH system?

The LungFit PH is an FDA-approved system developed by Beyond Air that generates nitric oxide on-demand from ambient air, enabling the delivery of unlimited, on-demand nitric oxide for treating various lung diseases.

Has Beyond Air recently secured additional funding?

In September 2024, Beyond Air announced a $20.6 million private placement offering priced at-the-market under Nasdaq rules.

What strategic partnership did Beyond Air form in September 2023?

In September 2023, Beyond Air and Getz Healthcare entered a strategic collaboration to commercialize the LungFit PH system in the Asia-Pacific Region.